Host |
Mouse |
Klon |
SMab-1 |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Human Glioma Tissue |
Verdünnung |
- |
Isotyp |
Mouse IgG1 kappa |
Lokalisation |
Cytoplasmic, nucleus |
IDH1 R132S
|
Diagnostic Biosystems |
SMab-1 |
6 ml |
Ready-to-use |
RUO |
PDM582R |
-
|
Host |
Sheep |
Klon |
polyclonal |
Format |
Purified |
Methode |
WB, P |
Vorbehandlung |
Citrate |
Isotyp |
Sheep IgG |
Verdünnung |
Recombinant human indoleamine 2,3 - dioxygenase |
IDO (Indoleamine 2,3-Dioxygenase)
|
Zytomed Systems GmbH |
polyclonal |
100 µl |
Purified |
RUO |
609-0003 |
-
|
Host |
Mouse |
Klon |
UMAB126 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
IgG1 |
Lokalisation |
Membrane, Cytoplasm |
IDO1
|
Biocare Medical |
UMAB126 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3210A |
-
|
Host |
Mouse |
Klon |
UMAB126 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
IgG1 |
Lokalisation |
Membrane, Cytoplasm |
IDO1
|
Biocare Medical |
UMAB126 |
0.5 ml |
Concentrate |
CE/IVD |
ACI3210B |
-
|
Host |
Mouse |
Klon |
UMAB126 |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
IgG1 |
Lokalisation |
Membrane, Cytoplasm |
IDO1
|
Biocare Medical |
UMAB126 |
6 ml |
Ready-to-use |
CE/IVD |
API3210AA |
-
|
Host |
Rabbit |
Klon |
ZR291 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
? |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
? |
Lokalisation |
? |
IgA
|
Zeta Corporation |
ZR291 |
1 ml |
Concentrate |
CE/IVD |
Z2729RL |
-
|
Host |
Rabbit |
Klon |
ZR291 |
Format |
r-t-u |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
? |
Verdünnung |
- |
Isotyp |
IgG |
Verdünnung |
? |
Lokalisation |
? |
IgA
|
Zeta Corporation |
ZR291 |
7 ml |
r-t-u |
CE/IVD |
Z2729RP |
-
|
Host |
Rabbit |
Klon |
ZR291 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
? |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
? |
Lokalisation |
? |
IgA
|
Zeta Corporation |
ZR291 |
0.5 ml |
Concentrate |
CE/IVD |
Z2729RS |
-
|
Host |
Rabbit |
Klon |
ZR291 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
? |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
? |
Lokalisation |
? |
IgA
|
Zeta Corporation |
ZR291 |
0.1 ml |
Concentrate |
CE/IVD |
Z2729RT |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Verdünnung |
1:20 - 1:40 |
Isotyp |
Rabbit Ig |
IgA-FITC
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
F007 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Verdünnung |
1:20 - 1:40 |
Isotyp |
Rabbit Ig |
IgA-FITC
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
F007-01 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Ready-to-use |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgA, Human
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR017 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgA, Human
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP020 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgA, Human
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP020-01 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgA, Human
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP020-05 |
-
|
Host |
Goat |
Klon |
polyclonal |
Format |
Purified |
Methode |
F, WB, EL |
Isotyp |
Goat IgG |
Verdünnung |
Native human IgA |
IgA, Human (Alpha Chain)
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0062 |
-
|
Host |
Mouse |
Klon |
Mc29-12 |
Format |
Purified |
Methode |
F, P, EL |
Isotyp |
Mouse IgG1 |
IgA, Human (Secretory Component)
|
Zytomed Systems GmbH |
Mc29-12 |
200 µg |
Purified |
RUO |
609-0066 |
-
|
Host |
Rabbit |
Klon |
ZR156 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Lymph node |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
Full-length human IGHD protein |
Lokalisation |
Cytoplasm |
IgD (ZR156)
|
Zeta Corporation |
ZR156 |
1 ml |
Concentrate |
CE/IVD |
Z2696RL |
-
|
Host |
Rabbit |
Klon |
ZR156 |
Format |
ready-to-use |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Lymph node |
Verdünnung |
--- |
Isotyp |
IgG |
Verdünnung |
Full-length human IGHD protein |
Lokalisation |
Cytoplasm |
IgD (ZR156)
|
Zeta Corporation |
ZR156 |
7 ml |
ready-to-use |
CE/IVD |
Z2696RP |
-
|
Host |
Rabbit |
Klon |
ZR156 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Lymph node |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
Full-length human IGHD protein |
Lokalisation |
Cytoplasm |
IgD (ZR156)
|
Zeta Corporation |
ZR156 |
0.5 ml |
Concentrate |
CE/IVD |
Z2696RS |
-
|
Host |
Rabbit |
Klon |
ZR156 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
EDTA |
Positivkontrolle |
Lymph node |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
Full-length human IGHD protein |
Lokalisation |
Cytoplasm |
IgD (ZR156)
|
Zeta Corporation |
ZR156 |
0.1 ml |
Concentrate |
CE/IVD |
Z2696RT |
-
|
Host |
Rabbit |
Klon |
ZR247 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node |
Verdünnung |
1:50-200 |
Isotyp |
IgG |
Verdünnung |
Recombinant full-length human IGHG protein |
Lokalisation |
Cytoplasm |
IgG
|
Zeta Corporation |
ZR247 |
1 ml |
Concentrate |
CE/IVD |
Z2722RL |
-
|
Host |
Rabbit |
Klon |
ZR247 |
Format |
r-t-u |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node |
Verdünnung |
- |
Isotyp |
IgG |
Verdünnung |
Recombinant full-length human IGHG protein |
Lokalisation |
Cytoplasm |
IgG
|
Zeta Corporation |
ZR247 |
7 ml |
r-t-u |
CE/IVD |
Z2722RP |
-
|
Host |
Rabbit |
Klon |
ZR247 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node |
Verdünnung |
1:50-200 |
Isotyp |
IgG |
Verdünnung |
Recombinant full-length human IGHG protein |
Lokalisation |
Cytoplasm |
IgG
|
Zeta Corporation |
ZR247 |
0.5 ml |
Concentrate |
CE/IVD |
Z2722RS |
-
|
Host |
Rabbit |
Klon |
ZR247 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node |
Verdünnung |
1:50-200 |
Isotyp |
IgG |
Verdünnung |
Recombinant full-length human IGHG protein |
Lokalisation |
Cytoplasm |
IgG
|
Zeta Corporation |
ZR247 |
0.1 ml |
Concentrate |
CE/IVD |
Z2722RT |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Purified |
Methode |
F, EL |
Isotyp |
Rabbit IgG |
Verdünnung |
Goat IgG, whole molecule |
IgG (H&L), Caprine
|
Zytomed Systems GmbH |
polyclonal |
2 mg (2 ml) |
Purified |
RUO |
609-0180 |
-
|
Host |
Goat F(ab')2 |
Klon |
polyclonal |
Format |
Lyophilised |
Methode |
FL |
Verdünnung |
1:5 |
Isotyp |
Goat IgG |
Verdünnung |
Purified mouse IgG |
IgG (H&L), Mouse - PE
|
Zytomed Systems GmbH |
polyclonal |
1 ml |
Lyophilised |
RUO |
609-0228E |
-
|
Host |
Goat |
Klon |
polyclonal |
Format |
Purified |
Methode |
EL |
Isotyp |
Goat IgG |
Verdünnung |
Native Rabbit IgG whole molecule |
IgG (H&L), Rabbit
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0244 |
-
|
Host |
Goat |
Klon |
polyclonal |
Format |
Lyophilised |
Methode |
F, WB, EL |
Isotyp |
Goat IgG |
Verdünnung |
Rat IgG, whole molecule |
IgG (H&L), Rat - Biotin
|
Zytomed Systems GmbH |
polyclonal |
2 mg |
Lyophilised |
RUO |
609-0262B |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Verdünnung |
1:20 - 1:40 |
Isotyp |
Rabbit Ig |
IgG-FITC
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
F008 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Verdünnung |
1:20 - 1:40 |
Isotyp |
Rabbit Ig |
IgG-FITC
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
F008-01 |
-
|
Host |
Mouse |
Klon |
RWP49 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:50 - 1:100 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cytoplasm and cell membrane |
IgG, Human
|
Biocare Medical |
RWP49 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3185A |
-
|
Host |
Mouse |
Klon |
RWP49 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:50 - 1:100 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cytoplasm and cell membrane |
IgG, Human
|
Biocare Medical |
RWP49 |
0.5 ml |
Concentrate |
CE/IVD |
ACI3185B |
-
|
Host |
Mouse |
Klon |
RWP49 |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cytoplasm and cell membrane |
IgG, Human
|
Biocare Medical |
RWP49 |
6 ml |
Ready-to-use |
CE/IVD |
API3185AA |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Ready-to-use |
Methode |
F, P |
Vorbehandlung |
Trypsin |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgG, Human
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR018 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Trypsin |
Positivkontrolle |
Tonsil |
Verdünnung |
1:200 - 1:500 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgG, Human
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP023 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Trypsin |
Positivkontrolle |
Tonsil |
Verdünnung |
1:200 - 1:500 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgG, Human
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP023-01 |
-
|
Host |
Rabbit |
Klon |
polyclonal |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Trypsin |
Positivkontrolle |
Tonsil |
Verdünnung |
1:200 - 1:500 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cytoplasm |
IgG, Human
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP023-05 |
-
|
Host |
Sheep |
Klon |
polyclonal |
Format |
Purified |
Methode |
F, FL |
Isotyp |
Sheep IgG |
Verdünnung |
Rabbit IgG |
IgG, Rabbit - FITC
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0403C |
-
|
Host |
Sheep |
Klon |
polyclonal |
Format |
Lyophilised |
Methode |
FL |
Verdünnung |
1:5 - 1:10 |
Isotyp |
Sheep IgG |
Verdünnung |
Rabbit IgG |
IgG, Rabbit - PE
|
Zytomed Systems GmbH |
polyclonal |
100 Tests |
Lyophilised |
RUO |
609-0406E |
-
|
Host |
Rabbit F(ab')2 |
Klon |
polyclonal |
Format |
Purified |
Methode |
EL |
Verdünnung |
1:250 - 1:1000 |
Isotyp |
Rabbit IgG |
Verdünnung |
Purified polyclonal rat IgG |
IgG, Rat
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0408 |
-
|
Host |
Goat |
Klon |
polyclonal |
Format |
Purified |
Methode |
EL, FL |
Isotyp |
Goat IgG |
Verdünnung |
Rat IgG |
IgG, Rat
|
Zytomed Systems GmbH |
polyclonal |
500 µg |
Purified |
RUO |
609-0409 |
-
|
Host |
Goat F(ab')2 |
Klon |
polyclonal |
Format |
Purified |
Methode |
FL |
Verdünnung |
1:25 - 1:100 |
Isotyp |
Goat IgG |
Verdünnung |
Rat IgG |
IgG, Rat - FITC
|
Zytomed Systems GmbH |
polyclonal |
0.5 ml |
Purified |
RUO |
609-0417C |
-
|
Host |
Rabbit F(ab')2 |
Klon |
polyclonal |
Format |
Purified |
Methode |
P, F, EL |
Isotyp |
Rabbit IgG |
Verdünnung |
Purified rat immunoglobulin G |
IgG, Rat - HRP
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0420D |
-
|
Host |
Goat |
Klon |
polyclonal |
Format |
Purified |
Methode |
P, F, EL |
Isotyp |
Goat IgG |
Verdünnung |
Rat IgG |
IgG, Rat - HRP
|
Zytomed Systems GmbH |
polyclonal |
500 µg |
Purified |
RUO |
609-0421D |
-
|
Host |
Goat F(ab')2 |
Klon |
polyclonal |
Format |
Lyophilised |
Methode |
FL |
Verdünnung |
1:5 - 1:10 |
Isotyp |
Goat IgG |
IgG, Rat - PE
|
Zytomed Systems GmbH |
polyclonal |
100 Tests |
Lyophilised |
RUO |
609-0424E |
-
|
Host |
Mouse |
Klon |
8c/6-39 (HP6091) |
Format |
Purified |
Methode |
F, EL |
Isotyp |
Mouse IgG2a |
Verdünnung |
Purified human IgG1 |
IgG1 Fc, Human
|
Zytomed Systems GmbH |
8c/6-39 (HP6091) |
200 µg |
Purified |
RUO |
609-0427 |
-
|
Host |
Rat |
Klon |
LO-MG1-2 |
Format |
Purified |
Methode |
EL |
Verdünnung |
50 µg/mL |
Isotyp |
Rat IgG1 |
Verdünnung |
Purified mouse IgG1 from Balb/c mice |
IgG1 Heavy Chain, Mouse
|
Zytomed Systems GmbH |
LO-MG1-2 |
250 µg |
Purified |
RUO |
609-0428 |
-
|
Host |
Rat |
Klon |
LO-MG1-2 |
Format |
Purified |
Methode |
EL |
Verdünnung |
500 ng/mL |
Isotyp |
Rat IgG1 |
Verdünnung |
Monoclonal mouse IgG1 |
IgG1 Heavy Chain, Mouse - Biotin
|
Zytomed Systems GmbH |
LO-MG1-2 |
500 µg |
Purified |
RUO |
609-0429B |
-
|
Host |
Rat |
Klon |
LO-MG1-2 |
Format |
Purified |
Methode |
FL |
Verdünnung |
5 µg/mL |
Isotyp |
Rat IgG1 |
Verdünnung |
Purified mouse IgG1 from Balb/c mice |
IgG1 Heavy Chain, Mouse - FITC
|
Zytomed Systems GmbH |
LO-MG1-2 |
500 µg |
Purified |
RUO |
609-0430C |
-
|